124 related articles for article (PubMed ID: 6405338)
21. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
22. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
23. Hexamethylmelamine: a critical review of an active drug.
Foster BJ; Harding BJ; Leyland-Jones B; Hoth D
Cancer Treat Rev; 1986 Dec; 13(4):197-217. PubMed ID: 3102057
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer.
Mattsson W; von Eyben F; Hallsten L; Bjelkengren G
Cancer; 1982 Jan; 49(2):217-20. PubMed ID: 6797721
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
26. Hexamethylmelamine chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Copeland LJ; Gershenson DM
Obstet Gynecol; 1981 Sep; 58(3):361-3. PubMed ID: 6791063
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of mitomycin-C in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
Joss RA; Obrecht JP; Senn HJ; Alberto P; Sauter C; Cavalli F
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1477-9. PubMed ID: 6094197
[TBL] [Abstract][Full Text] [Related]
28. Phase I trial of pentamethylmelamine.
Ajani JA; Cabanillas FF; Bodey GP
Cancer Treat Rep; 1982 May; 66(5):1227-8. PubMed ID: 6805950
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
De Jager RL; Magill GB; Golbey RB; Krakoff IH
Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
[No Abstract] [Full Text] [Related]
30. Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.
Ihde DC; Dutcher JS; Young RC; Cordes RS; Barlock AL; Hubbard SM; Jones RB; Boyd MR
Cancer Treat Rep; 1981; 65(9-10):755-62. PubMed ID: 6791819
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
[TBL] [Abstract][Full Text] [Related]
32. Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myeloma.
Oken MM; Lenhard RE; Tsiatis AA; Glick JH; Silverstein MN
Cancer Treat Rep; 1987 Sep; 71(9):807-11. PubMed ID: 3113729
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Bonomi PD; Pazdur R; Stolbach L; Mason B; Ettinger D
Cancer Treat Rep; 1986 Dec; 70(12):1447-8. PubMed ID: 3024827
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
36. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
Foster BJ; Clagett-Carr K; Marsoni S; Simon R; Leyland-Jones B
Cancer Treat Rep; 1986 Aug; 70(8):1003-14. PubMed ID: 3089597
[TBL] [Abstract][Full Text] [Related]
37. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; RodinĂ² C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
38. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778
[TBL] [Abstract][Full Text] [Related]
39. Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
Fabian CJ; Rasmussen S; Stephens R; Haut A; Smith F; Balcerzak S; Tranum B
Cancer Treat Rep; 1979 Aug; 63(8):1359-61. PubMed ID: 113095
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.
Mallinson CN; Rake MO; Cocking JB; Fox CA; Cwynarski MT; Diffey BL; Jackson GA; Hanley J; Wass VJ
Br Med J; 1980 Dec; 281(6255):1589-91. PubMed ID: 7004559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]